Leverette (Ethinylestradiol, Levonorgestrel | Lactose)

Ethinylestradiol and Levonorgestrel, the active ingredients in Leverette, are a combined oral contraceptive presented as a tablet for oral use. It prevents pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus and endometrial lining.

GNH USA supplies Leverette as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Leverette, a combined oral contraceptive, acts on the hormonal regulation pathway to prevent unintended pregnancy. - Prevention of pregnancy: provides reliable contraception for women of childbearing age. - Menstrual cycle regulation: helps to achieve more predictable menstrual bleeding patterns. - Management of dysmenorrhea: reduces menstrual pain associated with ovulatory cycles.

Leverette may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Breast tenderness: temporary swelling or discomfort. - Headache: occasional mild to moderate pain. - Spotting or breakthrough bleeding: irregular light bleeding. - Mood changes: mild fluctuations in mood. - Weight gain: slight increase in body weight.

Serious or Rare Side Effects: - Thromboembolic events: deep vein thrombosis or pulmonary embolism. - Severe hypertension: sudden increase in blood pressure. - Hepatic adenoma: benign liver tumor. - Allergic reaction: rash, itching, or swelling. - Visual disturbances: blurred vision or loss of vision. - Stroke: rare cerebrovascular accident.

Before prescribing Leverette, clinicians should assess individual risk factors and counsel patients on safe use. - Assess thrombotic risk: evaluate personal or family history of clotting disorders. - Review cardiovascular status: consider hypertension, smoking, or age over 35. - Screen for liver disease: avoid use in active hepatic impairment. - Counsel on medication adherence: missed tablets reduce efficacy. - Discuss potential drug‑drug interactions: especially enzyme‑inducing agents. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Leverette can interact with several medicines that alter hormone levels or increase adverse event risk.

Major Interactions (Avoid): - Strong enzyme inducers (e.g., rifampin, carbamazepine): may reduce contraceptive effectiveness. - Certain antiretrovirals (e.g., protease inhibitors): can alter hormone metabolism. - Azole antifungals (e.g., ketoconazole): may increase hormone concentrations.

Moderate Interactions (Monitor Closely): - SSRIs and other antidepressants: may increase risk of bleeding. - St. John's wort: may decrease contraceptive efficacy. - Anticonvulsants with moderate inducing effect: monitor for breakthrough bleeding.